Provided by Tiger Trade Technology Pte. Ltd.

GENSCRIPT BIO

37.220
+4.66014.31%
Volume:60.00M
Turnover:2.20B
Market Cap:84.86B
PE:-19.30
High:38.280
Open:33.400
Low:33.020
Close:32.560
52wk High:38.280
52wk Low:10.360
Shares:2.28B
HK Float Shares:2.28B
Volume Ratio:1.98
T/O Rate:2.63%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.928
ROE:-15.33%
ROA:1.54%
PB:2.78
PE(LYR):-19.30
PS:12.80

Loading ...

Movement Alert|GENSCRIPT BIO Rises 4.18% in Regular Trading, Multiple Institutions Raise Target Prices Following Earnings Beat

Market Focus
·
Aug 19

China's GenScript Biotech H1 Revenue Rises on AI Drug Discovery

Reuters
·
Aug 18

Genscript Biotech Corp H1 Revenue USD 319 Million

THOMSON REUTERS
·
Aug 18

GenScript Adjusted Net Profit More than Triples to Us$62.5 Million in FY26 H1; Revenue Rises 27.3% to Us$404.2 Million

Reuters
·
Aug 18

Genscript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles

THOMSON REUTERS
·
Aug 18

Global Food Inflation Risks Return While Robotics Stocks Rally on Yushu Tech's Upcoming Debut

Stock News
·
Aug 18

Hong Kong Stocks Decline 0.3% in Early Trading

Dow Jones
·
Aug 18

HK Movers | Pharma Stocks Rally With Genscript Biotech up 6%, WuXi Biologics up 5%

Tiger Newspress
·
Aug 18

Movement Alert|GENSCRIPT BIO Rises 7.82% in Regular Trading, Interim Results Significantly Beat Expectations with AIDD Business Doubling

Market Focus
·
Aug 18

Genscript Biotech (SEHK:1548) Stock Near Doubles As Losses Deepen

Simply Wall St.
·
Aug 17

Asian Market's Estimated Value Stocks For August 2026

Simply Wall St.
·
Aug 17

Hong Kong Stock Moves: GENSCRIPT BIO Surges Over 4% as AIDD-Related Business Doubles in First Half

Stock News
·
Aug 17

HK Movers | Pharma Stocks Gain With HUTCHMED up 8%, JOINN up 6%

Tiger Newspress
·
Aug 17

Movement Alert|GENSCRIPT BIO Rises 3.3% in Regular Trading, H1 Adjusted Net Profit Surges 203% as AIDD Demand Accelerates

Market Focus
·
Aug 17

Genscript Biotech Widens Net Loss in H1

MT Newswires Live
·
Aug 17

GENSCRIPT BIO 2026 Interim Results: Soaring AIDD Demand Unlocks Vast Market Opportunities, Revenue and Profit Growth Far Exceeds Expectations, Core Businesses Achieve Comprehensive Breakthrough

Deep News
·
Aug 16

GenScript Biotech Posts 27.3% Revenue Growth and 203.3% Surge in Adjusted Profit in H1 2026, While Equity Accounting Hit Drives US$129.34 Million Net Loss

Bulletin Express
·
Aug 16

Genscript Biotech Says H1 Adjusted Net Profit up 203.3% Y/Y, Revenue up 27.3%

THOMSON REUTERS
·
Aug 16

GENSCRIPT BIO Reports Interim Results: Net Loss Narrows 29.25% to $129 Million

Stock News
·
Aug 16

GenScript FY26 H1 Net Loss Narrows 28.9% to US$ 129.34 Million; Revenue Rises 27.3% to US$ 404.22 Million

Reuters
·
Aug 16